Lily Chu
Lily Chu, MD, MSHS, is board certified in both internal medicine and geriatric medicine.[1]
Contents
Education[edit | edit source]
- Geriatric Medicine Fellowship, University of California, Los Angeles
- MSHS, Public Health, University of California, Los Angeles
- Internal Medicine Residency, University of Rochester
- MD, University of Washington
- BS, Biology, University of Washington[2]
Boards and Committees[edit | edit source]
- Community Advisory Board Member at Stanford University Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Initiative[3]
- Co-Vice president of the International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[4]
- Panel member of the 2015 Institute of Medicine report: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness[5]
ME/CFS Common Data Elements (CDE) Project[edit | edit source]
Dr Chu is Co-chair of Post-exertional Malaise Working Group and a member of the Sleep Working Group and the Biomarkers Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Elements (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[6]
Quotes[edit | edit source]
- 2016, "Ultimately the best way to prevent suicide in ME/CFS will be to find effective disease-modifying treatments or cures for it."[7]
Publications[edit | edit source]
- 2012, "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise," Letter to the Editor, European Journal of Clinical Investigation[8]
- Preliminary Results – April 2013 FDA Workshop Survey, By Lily Chu, Leonard Jason, Madison Sunnquist, and Suzanna So
- May 2016, [http:http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx Suicide and ME/CFS -- Lily Chu, MD, MSHS]
- 2017, Article commentary - Differences of opinion on systemic exercise intolerance disease are not ‘mistakes’: a rejoinder to Jason Sunnquist, Gleason and Fox[9]
Open Letter to The Lancet[edit | edit source]
Three open letters to the editor of The Lancet have been sent urging the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chu, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
Notable studies[edit | edit source]
- 2021, Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[10] - (Full text)
- 2021, Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[11] - (Full text)
- 2020, Environmental accommodations for university students affected by myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS)[12] - (Full text)
- 2019, Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome[13] - (Full text)
- 2018, Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey[14] - (Full Text)
- 2017, Cytokine signature associated with disease severity in chronic fatigue syndrome patients[15] - (Full Text)
- 2017, Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria[16]
- 2013, Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology[17] - (Full Text)
Talks and interviews[edit | edit source]
HHS/CFSAC Testimony[edit | edit source]
- CFSAC Public Testimony December 2014
- Written Testimony for June 2012 meeting
- Written Testimony for Nov 2011 meeting
- Written Testimony for May 2011 meeting
- Written Testimony for October 2009 meeting
Online presence[edit | edit source]
- Youtube
- Website
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Lily Chu". Retrieved February 7, 2019.
- ↑ "Lily Chu". LinkedIn. Retrieved February 7, 2019.
- ↑ Stanford ME/CFS Initiative. "Meet the Team". ME/CFS Initiative. Retrieved February 7, 2019.
- ↑ International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. "Leadership of the IACFS". Retrieved February 7, 2019.
- ↑ Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press. doi:10.17226/19012. ISBN 0309316898. PMID 25695122.
- ↑ "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
- ↑ http:http://iacfsme.org/PDFS/2016MayNesletter/Attachment-03-Dr-Lily-Chu-ME-CFS-and-suicide.aspx
- ↑ Chu, Lily; Friedberg, Fred; Friedman, Kenneth J.; Littrell, Nereida; Stevens, Staci; Vallings, Ros (2012). "Exercise and chronic fatigue syndrome: maximize function, minimize post-exertional malaise". European Journal of Clinical Investigation. 42 (12): 1362–1362. doi:10.1111/j.1365-2362.2012.02723.x. ISSN 1365-2362.
- ↑ Chu, Lily; Valencia, Ian J.; Montoya, Jose G. (2017). "Differences of opinion on systemic exercise intolerance disease are not 'mistakes': a rejoinder to Jason Sunnquist, Gleason and Fox". Fatigue: Biomedicine, Health & Behavior. doi:10.1080/21641846.2017.1362750.
- ↑ Montoya, Jose; Dowell, Theresa; Mooney, Amy; Dimmock, Mary; Chu, Lily (October 6, 2021). "Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (10): 1331. doi:10.3390/healthcare9101331. ISSN 2227-9032. PMC 8544443. PMID 34683011.
- ↑ Chu, Lily; Elliott, Meghan; Stein, Eleanor; Jason, Leonard A. "Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Healthcare. 9 (6): 629. doi:10.3390/healthcare9060629. ISSN 2227-9032. PMC 8227525. PMID 34070367.
- ↑ Chu, Lily; Fuentes, Lynn R.; Marshall, Olena M.; Mirin, Arthur A. (January 1, 2020). "Environmental accommodations for university students affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Work. 66 (2): 315–326. doi:10.3233/WOR-203176. ISSN 1051-9815.
- ↑ Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (February 5, 2019). "Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Pediatrics. 7 (12). doi:10.3389/fped.2019.00012.
- ↑ Chu, Lily; Valencia, Ian J.; Garvert, Donn W.; Montoya, Jose G. (June 1, 2018). "Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey". PLOS One. 13 (1): e0197811. doi:10.1371/journal.pone.0197811.
- ↑ Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017). "Cytokine signature associated with disease severity in chronic fatigue syndrome patients". Proceedings of the National Academy of Sciences of the United States of America. 114 (34): E7150-E7158. doi:10.1073/pnas.1710519114.
- ↑ Chu, Lily; Norris, Jane; Valencia, Ian J.; Montoya, Jose G. (2017). "Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria". Fatigue: Biomedicine, Health & Behavior. 5. doi:10.1080/21641846.2017.1299079.
- ↑ Stringer, EA; Baker, KS; Carrol, IR; Montoya, JG; Chu, L; Maeker, HT; Younger, JW (April 9, 2013). "Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: Evidence of inflammatory pathology,". J Transl Med. doi:10.1186/1479-5876-11-93. PMID 23570606.
myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.
myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.
Chronic Fatigue Syndrome Advisory Committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.
National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.